Solid Biosciences (SLDB) Tops Q4 EPS by 17c

Solid Biosciences (NASDAQ: SLDB) reported Q4 EPS of ($0.53), $0.17 better than the analyst estimate of ($0.70).

For earnings history and earnings-related data on Solid Biosciences (SLDB) click here.

You May Also Be Interested In

• Apple announced foldable iPhone Duo, starting at $1,999
• Sprouts Farmers Market (SFM) call put ratio 8.7 calls to 1 put with a focus on 5400 contracts of January 110 calls as share price down 2.2%
• Medical Properties Trust (MPT) call put ratio 1 call to 6.8 puts with a focus on December 4 calls and June 2.5 puts as share price down 1.6%